Literature DB >> 23975360

The role of hemostatic mechanisms in the development of thrombosis in Behcet's disease: an analysis by modified rotation thromboelastogram (ROTEM).

N Şule Yaşar Bilge1, O Meltem Akay, Timuçin Kaşifoğlu, Gökhan Kuş, Cengiz Korkmaz.   

Abstract

Behcet's disease (BD) is a multisystemic disorder characterised by recurrent oral and genital ulcers. Vasculitis and thrombotic events are the most important causes of mortality. Thrombosis is the major clinical finding in patients with BD, but the cause of the thrombosis is still unclear. Thromboelastography is an alternative method to evaluate almost all steps of the hemostatic system. Today, the modified rotation thromboelastogram (ROTEM) is a newer coagulation test and a more powerful technique. Our aim in this study was to investigate whether hemostatic mechanisms play a role in the development of thrombosis in BD patients by using ROTEM. Thirty BD patients, 20 ankylosing spondylitis patients, and 14 healthy controls who are not taking anti-aggregant or anti-coagulant therapy were included in the study. Whole blood count, protrombin time, activated protrombin time, fibrinogen, D-dimer levels, and ROTEM parameters (clotting time, clot formation time (CFT), and maximum clot formation(MCF)) were determined by INTEM and EXTEM analysis. Of the 30 patients with BD, 19 were women and 11 were men, and mean age was 40.6 ± 11.2. Two of the BD patients had vascular involvement, but none of them were in active phase of the disease during the study. In INTEM assay, MCF (p < 0,001) value was significantly increased, and CFT (p>0.05) value was decreased in BD patients compared with the control group. In the EXTEM assay, there was a similar significant increase in MCF (p=0.002) value and a decrease in CFT (p=0.002) value in BD patients compared with the control group. The results of our study indicated that primary hemostatic mechanisms which can be detected by ROTEM may play a role in the development of thrombosis in patients with BD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975360     DOI: 10.1007/s10067-013-2368-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Thrombelastography in healthy volunteers, patients with stable angina and acute chest pain.

Authors:  R Artang; E Jensen; F Pedersen; N J Frandsen
Journal:  Thromb Res       Date:  2000-03-15       Impact factor: 3.944

Review 2.  Behçet's disease and thrombophilia.

Authors:  M Leiba; Y Sidi; H Gur; A Leiba; M Ehrenfeld
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

Review 3.  Thrombelastography.

Authors:  N Salooja; D J Perry
Journal:  Blood Coagul Fibrinolysis       Date:  2001-07       Impact factor: 1.276

4.  Haemostatic changes during surgery for primary brain tumours.

Authors:  K Y Goh; W C Tsoi; C S Feng; N Wickham; W S Poon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

Review 5.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

Review 6.  Inflammation-induced thrombosis: mechanisms, disease associations and management.

Authors:  Kenan Aksu; Ayhan Donmez; Gokhan Keser
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Proceedings: Hypercoagulability. Thrombelastographic monitoring during extensive hepatic surgery.

Authors:  W S Howland; E B Castro; J B Fortner; P Gould
Journal:  Arch Surg       Date:  1974-04

8.  Thrombelastography of blood from subjects with chronic renal failure.

Authors:  D S Holloway; J P Vagher; J A Caprini; N M Simon; L F Mockros
Journal:  Thromb Res       Date:  1987-03-15       Impact factor: 3.944

9.  Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery.

Authors:  E Mahla; T Lang; M N Vicenzi; G Werkgartner; R Maier; C Probst; H Metzler
Journal:  Anesth Analg       Date:  2001-03       Impact factor: 5.108

10.  Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans.

Authors:  A O Spiel; F B Mayr; C Firbas; P Quehenberger; B Jilma
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

View more
  4 in total

1.  Rotational thromboelastometry (ROTEM) in Behçet's disease.

Authors:  I Fernández-Bello; F J López-Longo; E G Arias-Salgado; V Jiménez-Yuste; N V Butta
Journal:  Clin Rheumatol       Date:  2013-11       Impact factor: 2.980

2.  Can we predict thrombotic tendency in rheumatoid arthritis? A thromboelastographic analysis (with ROTEM).

Authors:  Sümeyye Merve Türk; Döndü Üsküdar Cansu; Hava Üsküdar Teke; Timuçin Kaşifoğlu; O Meltem Akay; Muzaffer Bilgin; Cengiz Korkmaz
Journal:  Clin Rheumatol       Date:  2018-05-07       Impact factor: 2.980

3.  Evaluation of Coagulation Profile in Children with Type 1 Diabetes Mellitus Using Rotational Thromboelastometry.

Authors:  Cigdem Binay; Ayse Bozkurt Turhan; Enver Simsek; Ozcan Bor; Olga Meltem Akay
Journal:  Indian J Hematol Blood Transfus       Date:  2017-02-28       Impact factor: 0.900

4.  Evaluating hypercoagulability in new-onset systemic lupus erythematosus patients using thromboelastography.

Authors:  Huiyun Gong; Ce Shi; Zhuochao Zhou; Jialin Teng; Yue Sun; Chengde Yang; Xuefeng Wang; Junna Ye
Journal:  J Clin Lab Anal       Date:  2019-12-16       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.